Beauty Farm Medical and Health Industry Inc. (2373) announced on October 28, 2025, the repurchase of 30,000 shares on the market for a total transaction amount of approximately HK$917,220, at an average price of around HK$30.57 per share.

From October 15, 2025, to the date of this announcement, the cumulative number of repurchased shares reached 445,000, with a total consideration of about HK$14,142,070. According to information disclosed, the company’s board of directors considers the current trading price of its shares undervalued compared to the intrinsic value and business prospects. The share repurchase is viewed as conducive to enhancing the company’s capital market value and delivering returns to shareholders.

Based on the announcement, the share repurchase was conducted under a general mandate granted at the annual general meeting held on June 27, 2025, which allows the company to repurchase up to 23,579,556 shares, representing 10% of the shares in issue as of that date.

The announcement also advises shareholders and potential investors to note that no guarantee can be made regarding the specific timing, quantity, or price of any further share repurchases, and to exercise caution when dealing in the company’s securities.